These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 18109277)

  • 1. Nitrogen mustard therapy; the use of methyl bis (B chloroethyl) amine hydrochloride in Hodgkin's disease, leukemia, lymphosarcoma and cancer of the lung.
    BEN-ASHER S
    Am J Med Sci; 1949 Feb; 217(2):162-8. PubMed ID: 18109277
    [No Abstract]   [Full Text] [Related]  

  • 2. Nitrogen mustard therapy; use of methyl-bis (beta-chloroethyl) amine hydrochloride and tris (beta-chloroethyl) amine hydrochloride for Hodgkin's disease, lymphosarcoma, leukemia and certain allied and miscellaneous disorders.
    GOODMAN LS; WINTROBE MM
    J Am Med Assoc; 1946 Sep; 132():126-32. PubMed ID: 20997191
    [No Abstract]   [Full Text] [Related]  

  • 3. The use of nitrogen mustard in Hodgkin's disease and lymphosarcoma.
    MEYER AH; OVERMILLER WC
    Ann Intern Med; 1949 Feb; 30(2):381-6. PubMed ID: 18109292
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effect of methyl-bis (beta-chloroethyl)amine hydrochloride on Hodgkin's disease, lymphosarcoma, leukemia and neoplasms].
    LEVI M; MENE G; FERRI A
    Riv Patol Clin; 1951 Jan; 6(1):1-58. PubMed ID: 14834735
    [No Abstract]   [Full Text] [Related]  

  • 5. The partition of radio-phosphorus (P32) in blood, urine and tumor tissue in patients with Hodgkin's disease and lymphosarcoma before and after treatment with nitrogen mustard [methyl bis (beta-chloroethyl) amine].
    MASOUREDIS SP; LOW-BEER BV; BIERMAN HR; CHERNEY LS; SHIMKIN MB
    J Natl Cancer Inst; 1950 Oct; 11(2):289-300. PubMed ID: 14795186
    [No Abstract]   [Full Text] [Related]  

  • 6. Nitrogen-mustard therapy for Hodgkin's disease, lymphosarcoma, the leukemias, and other disorders.
    WINTROBE MM; HUGULEY CM
    Cancer; 1948 Sep; 1(3):357-82. PubMed ID: 18887904
    [No Abstract]   [Full Text] [Related]  

  • 7. Landmark article Sept. 21, 1946: Nitrogen mustard therapy. Use of methyl-bis(beta-chloroethyl)amine hydrochloride and tris(beta-chloroethyl)amine hydrochloride for Hodgkin's disease, lymphosarcoma, leukemia and certain allied and miscellaneous disorders. By Louis S. Goodman, Maxwell M. Wintrobe, William Dameshek, Morton J. Goodman, Alfred Gilman and Margaret T. McLennan.
    Goodman LS; Wintrobe MM; Dameshek W; Goodman MJ; Gilman A; McLennan MT
    JAMA; 1984 May; 251(17):2255-61. PubMed ID: 6368885
    [No Abstract]   [Full Text] [Related]  

  • 8. Nitrogen mustards in the treatment of neoplastic disease.
    KARNOFSKY DA
    Adv Intern Med; 1950; 4():1-75. PubMed ID: 14770961
    [No Abstract]   [Full Text] [Related]  

  • 9. [Nitrogen mustard in the treatment of Hodgkin's disease, lymphosarcoma, leukemia and related diseases].
    de LORENZO J; JANNINI P
    Arq Clin (Rio De J); 1951 Mar; 12(3):141-61. PubMed ID: 14847898
    [No Abstract]   [Full Text] [Related]  

  • 10. Nitrogen mustard as a therapeutic agent for Hodgkin's disease, lymphosarcoma and leukemia.
    WINTROBE MM; HUGULEY CM
    Ann Intern Med; 1947 Oct; 27(4):529-40. PubMed ID: 20268426
    [No Abstract]   [Full Text] [Related]  

  • 11. Cytologic changes in bronchogenic carcinoma following treatment with nitrogen mustard (methyl-bis [beta-chloroethyl] amine).
    GAENSLEP EA; McKAY DG
    Arch Pathol (Chic); 1948 Dec; 46(6):503-18. PubMed ID: 18129234
    [No Abstract]   [Full Text] [Related]  

  • 12. Nitrogen mustard therapy in Hodgkin's disease, lympho-reticulosarcomatosis and lymphatic leukaemia.
    KIELER J
    Acta Radiol (Stockh); 1951 Dec; 36(6):461-8. PubMed ID: 14902587
    [No Abstract]   [Full Text] [Related]  

  • 13. [Nitrogen mustard therapy of proliferative blood diseases; methods, experiences as well as application possibilities in therapy of carcinoma].
    KLIMA R; HORNISCHER R
    Wien Med Wochenschr; 1953 Jan; 103(1):11-4. PubMed ID: 13049846
    [No Abstract]   [Full Text] [Related]  

  • 14. Chemical reactions of the nitrogen mustard gases; monosubstitution products of ethyl-bis (beta-chloroethyl)amine and methyl-bis (beta-chloroethyl)amine.
    GOLUMBIC C; FRUTON JS; BERGMANN M
    J Org Chem; 1946 Sep; 11(5):581-5. PubMed ID: 20280723
    [No Abstract]   [Full Text] [Related]  

  • 15. Nitrogen mustard therapy; clinical studies on the effects of methyl-bis (beta-chloroethyl) amine hydrochloride upon various types of neoplastic disease.
    ARIEL IM; KANTER L
    Am J Surg; 1949 Apr; 77(4):509-21. PubMed ID: 18113270
    [No Abstract]   [Full Text] [Related]  

  • 16. A comparative study of the effectiveness of HN2 and cyclophosphamide in bronchogenic carcinoma, Hodgkin's disease and lymphosarcoma.
    SPEAR PW; PATNO ME
    Cancer Chemother Rep; 1962 Feb; 16():413-5. PubMed ID: 13915594
    [No Abstract]   [Full Text] [Related]  

  • 17. Result of methyl-bis (beta-chloroethyl) amine hydrochloride therapy; a preliminary report of a nitrogen mustard.
    HETTIG RA
    Proc Annu Meet Cent Soc Clin Res U S; 1947; 20():40. PubMed ID: 20272802
    [No Abstract]   [Full Text] [Related]  

  • 18. [Nitrogen mustard therapy of various cases of malignant lymphogranuloma and lymphosarcoma].
    NARDI FL
    Accad Medica; 1952 Apr; 67(4):169-77. PubMed ID: 12984986
    [No Abstract]   [Full Text] [Related]  

  • 19. The clinical application of a nitrogen mustard compound methyl bis (beta-chloroethyl) amine to the treatment of neoplastic disorders of the hemopoietic system.
    SPURR CL; JACOBSON LO
    Cancer Res; 1947 Jan; 7(1):51. PubMed ID: 20278230
    [No Abstract]   [Full Text] [Related]  

  • 20. Nitrogen mustards in the treatment of Hodgkin's disease and lymphosarcoma.
    SHERRY M
    South Med J; 1948 Feb; 41(2):118-29. PubMed ID: 18898249
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.